Breaking News

You are here » Indian-Commodity  :  Commodities  :  Crude Oil  :  Crude palm oil futures trade higher on MCX

07-Aug2018

Crude palm oil futures trade higher on MCX

Crude palm oil futures traded higher on MCX, due to fresh buying by market players tracking  positive trend in Malaysia palm oil. Besides, strong physical demand from domestic markets also triggered the upward momentum.

The contract for August delivery was trading at Rs 593.70 , up by 0.27 % or Rs 1.60 from its previous closing of Rs 592.10. The open interest of the contract stood at 7533 lots

The contract for September delivery was trading at Rs 590.60, up by 0.46 % or Rs 2.70 from its previous closing of Rs 587.90. The open interest of the contract stood at 5229 lots on MCX.


Related News

View all news

Crude oil futures end higher as supplies tighten

Crude oil futures ended higher on Tuesday amid reports of falling Saudi Arabian exports. Crude-oil volumes shipped from major producer Saudi Arabia fell in the first half of February to 6.2 million barrels......

Crude oil futures decline on demand concerns

Crude oil futures declined on MCX as speculators reduced their bets, tracking weak international oil market on caution that economic growth may dent fuel demand this year. Though, global oil markets remain......

Mentha oil futures trade lower on higher acreage

Mentha oil futures traded lower on MCX, as speculators trimmed their positions on expectations of higher acreage under mint due to lucrative prices throughout last year. Though, fall in inventory at exchange-accredited......

Top News

View all news

Tata Motors signs LTS agreement with its employees

Tata Motors has signed a long-term wage settlement (LTS) agreement with its employees. Under the agreement, workmen will get a wage rise of Rs 9,000 per month along with other incentives based on performance.......

Canara Bank invites bids from merchant bankers to manage its $350-500 million MTN issue: Report

Canara Bank has reportedly invited bids from merchant bankers to manage its $350-500 million issue of senior unsecured/tier-II capital bonds under its medium-term note (MTN) programme. The issue size may......

Alembic Pharma gets USFDA's nod for Acetazolamide Extended-Release Capsules

Alembic Pharmaceuticals (Alembic) has received approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Acetazolamide Extended-Release Capsules, 500......